Infectious Disease Diagnostics Market by Product, Test Type, Disease, Technology, End User
The global infectious disease diagnostics market size is expected to reach USD 33.1 billion by 2027, from USD 35.5 billion in 2022, at -1. 4% CAGR. The market is driven by factors such as the indication of infectious diseases, the growing trend of POC testing, and growing technological advancements.
New York, June 21, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the publication of the report “Infectious Disease Diagnostics Market by Product, Test Type, Disease, Technology, End User – Global Forecast to 2027″ – https ://www.reportlinker.com/p06089287/?utm_source=GNW
However, an unfavorable repayment scenario is expected to restrain the market growth to some extent over the forecasted years.
Reagents, kits and consumables accounted for the largest market share in the infectious disease diagnostics market, by-product and service, during the forecast period
The infectious disease diagnostics market is segmented into reagents, kits and consumables; implements; and software and services. The reagents, kits and consumables segment accounted for the largest market share in the infectious disease diagnostics market in 2021.
Major factors driving the growth of this segment include increasing number of infectious disease diagnostic tests being performed, increasing need for more reliable, specific and timely detection of infectious diseases in early stages. It is the largest and fastest growing segment of the infectious disease diagnostics market.
In addition, the frequent need for reagents and kits makes it a recurring cost.
The mosquito-borne diseases segment accounted for the highest CAGR
Based on disease type, the infectious disease diagnostics market is segmented into COVID-19, HIV, hospital-acquired infections, hepatitis, Chlamydia trachomatis, Neisseria gonorrhea, HPV, tuberculosis, influenza, syphilis, mosquito-borne diseases and other diseases infectious. In 2021, the mosquito-borne diseases segment accounted for the highest CAGR.
The diagnostic laboratory segment accounted for the largest market share
On the basis of end users, the infectious disease diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, academic research institutes and other end users. The diagnostic laboratory segment accounted for the largest market share in 2021.
This can be attributed to the development of complex and highly specialized tests in the diagnosis of infectious diseases and the strengthening of health infrastructures for effective diagnosis and treatment of diseases.
The main interviews conducted for this report can be categorized as follows:
• By type of business: level 1 – 40%, level 2 – 30% and level 3 – 30%
• By designation: level C – 27%, level D – 18% and others – 55%
• By region: North America -51%, Europe – 21%, Asia-Pacific – 18%, Latin America – 6% and Middle East and Africa – 4%
Beds from companies featured in the report:
• Abbott Laboratories (USA)
• F. Hoffmann-La Roche SA (Switzerland)
• bioMérieux SA (France)
• Thermo Fisher Scientific Inc. (USA)
• Danaher Corporation (USA)
• Quidel Corporation (USA)
• Hologic, Inc. (USA)
• PerkinElmer Inc. (United States)
• Bio-Rad Laboratories, Inc. (USA)
• QIAGEN (Netherlands)
• Siemens Healthineers AG (Germany)
• Becton, Dickinson and Company (United States)
• DiaSorin SpA (Italy)
• Grifols SA (Spain)
• Sysmex Corporation (Japan)
• Seegene Inc. (South Korea)
• Orthoclinic diagnostics (United States)
• Genetic signatures (Australia)
• Meridian Bioscience (United States)
• OraSure Technologies (USA)
• Trinity Biotech Plc. (Ireland)
• Chembio diagnostic systems (USA)
• Co-diagnosis (United States)
• ELITech Group (France)
• Epitope diagnostics (USA)
• Trivitron Healthcare (India)
• Meril Life Sciences Pvt. ltd. (India)
• InBios International (USA)
• Uniogen Oy (Finland)
• Vela Diagnostics (Singapore)
This report provides a detailed picture of the global infectious disease diagnostics market. It aims to estimate the market size and future growth potential across different segments, such as product & service, test assay, technology, disease type, end-user, and region. .
The report also includes an in-depth competitive analysis of key market players along with their company profiles, recent developments, and key market strategies.
Key Benefits of Purchasing the Report:
The report will assist market leaders/new entrants by providing the closest approximations of revenue figures for the overall Infectious Disease Diagnostics market and its sub-segments. It will also help stakeholders better understand the competitive landscape and gain more information to better position their business. and develop appropriate go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with insights into the key market drivers, restraints, challenges and opportunities.
Read the full report: https://www.reportlinker.com/p06089287/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001